Mark Bultman

Mark Bultman serves as a key procurement lead within the Department of Veterans Affairs, overseeing the acquisition of critical medical laboratory services and diagnostic infrastructure to support veteran healthcare delivery. His role centers on ensuring timely, compliant, and mission-aligned procurement of high-complexity clinical testing capabilities, including molecular diagnostics, pathology services, and laboratory information systems. He operates within the agency’s broader strategy to modernize clinical diagnostics and expand access to precision medicine, managing full lifecycle contracts from solicitation through performance evaluation, with a strong emphasis on regulatory adherence and clinical outcome metrics. Bultman maintains sustained relationships with industry leaders including TRIWEST HEALTHCARE ALLIANCE CORP, OPTUM PUBLIC SECTOR SOLUTIONS, ORACLE HEALTH GOVERNMENT SERVICES, MCKESSON CORPORATION, and BOOZ ALLEN HAMILTON INC. These partnerships reflect a focus on large-scale, enterprise-level vendors capable of delivering integrated diagnostic platforms, data analytics for clinical decision support, and scalable laboratory operations across VA’s national network. His contracting approach prioritizes performance-based outcomes, service-level agreements, and interoperability with VA’s existing health information systems. Bultman’s procurement portfolio reflects a 100% non-set-aside orientation, indicating a strategic emphasis on competitive, open bidding to secure the highest-capability providers capable of meeting the VA’s complex, nationwide diagnostic demands. While small business participation is not formally prioritized through socioeconomic set-asides, his acquisitions remain open to all qualified vendors under full and open competition, consistent with VA’s mission to procure the most effective clinical solutions regardless of vendor size. His primary focus is NAICS 621511—Medical Laboratories—encompassing centralized and point-of-care diagnostic testing, specimen processing, pathology services, and laboratory automation systems. He procures advanced technologies including next-generation sequencing platforms, automated analyzers, LIS integration tools, and quality assurance frameworks critical to delivering timely, accurate clinical results for veteran care. His expertise lies at the intersection of clinical diagnostics, health IT infrastructure, and federal acquisition compliance.